Private capex bonanza!

Advertisement

So, private capex is out and kapow! Yes, it’s an extravaganza of investment with the March quarter delivering 6.1% growth against consensus of 4%. Year on year it is up 28.3%.

That’s all to the good, but I was more interested to see if capex projections had at all been reigned in in the March QTR following China’s slow down but nup!

Here’s the total:

Advertisement

These groovy charts show the projected (clear) and actual (shaded) capex. As you can see, the projection for Q213 is still big, really big! And it is all, you guessed it, mining:

Versus a manufacturing base that has pretty much thrown in the towel, planning investment at levels first achieved some six years ago.

Advertisement

Other industries are plumbing levels back in time that I dare not even canvass:

Advertisement

It’s all the way with DIRT!

More seriously, though, if you ignore the rampant Dutch disease, this is a very solid release given the external environment. I’m not surprised the dollar got .3 of a cent lift out of it. The one proviso I’ll add is that the first quarter was before the recent China slowdown consensus emerged. So, next quarter could be the release to watch for any peaking.

Update: Westpac notes that there has, in fact, been a slight ratcheting back in implied projected capex:

We calculate that the plans imply CAPEX growth of 23% for 2012/13, scaled back from 25% implied by the survey 3 months ago.

Advertisement

So we may indeed be approaching the peak.

About the author
David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific’s leading geo-politics and economics portal. He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.